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  In the present study, the antinociceptive profiles of Agrimonia pilosa Ledeb extract were examined 
in ICR mice. Agrimonia pilosa Ledeb extract administered orally (200 mg/kg) showed an antinociceptive 
effect as measured by the tail-flick and hot-plate tests. In addition, Agrimonia pilosa Ledeb extract 
attenuated the writhing numbers in the acetic acid-induced writhing test. Furthermore, the cumulative 
nociceptive response time for intrathecal (i.t.) injection of substance P (0.7 μg) was diminished by 
Agrimonia pilosa Ledeb extract. Intraperitoneal (i.p.) pretreatment with yohimbine (α 2-adrenergic 
receptor antagonist) attenuated antinociceptive effect induced by Agrimonia pilosa Ledeb extract in 
the writhing test. However, naloxone (opioid receptor antagonist) or methysergide (5-HT serotonergic 
receptor antagonist) did not affect antinociception induced by Agrimonia pilosa Ledeb extract in the 
writhing test. Our results suggest that Agrimonia pilosa Ledeb extract shows an antinociceptive 
property in various pain models. Furthermore, this antinociceptive effect of Agrimonia pilosa Ledeb 
extract may be mediated by α 2-adrenergic receptor, but not opioidergic and serotonergic receptors.
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INTRODUCTION
  Recently, natural products from plant origin possessing 
immense ethnopharmacological importance have been giv-
en the utmost priority as treatments for inflammation and 
allergic reactions [1,2]. Agrimonia pilosa Ledeb has been 
used traditionally for treatment of abdominal pain, sore 
throat, headaches, bloody discharge, parasitic infections 
and eczema in Korea and other Asian countries since cen-
turies [3]. Pharmacologically, Agrimonia pilosa Ledeb has 
been reported to possess anti-tumor [4,5], anti-viral [6,7], 
anti-oxidant [8], anti-microbial [9] and anti-hyperglycemic 
activity [10]. Reports also indicated that Agrimonia pilosa 
Ledeb extract inhibited the inflammatory process by sup-
pression of iNOS, ROS and inflammatory cytokine pro-
duction in microglial cells [11,12]. 
  However the detailed mechanisms of Agrimonia pilosa 
Ledeb in delivering anti-nociceptive profiles were not fully 
elucidated. Further, to date no report exists on the anti-no-
ciceptive effect of Agrimonia pilosa Ledeb. Therefore, in this 
study, we attempted to characterize antinociceptive profiles 
and mechanisms of Agrimonia pilosa Ledeb extract in vari-
ous pain models.
METHODS
  These experiments were approved by the University of 
Hallym Animal Care and Use Committee (Registration 
Number: Hallym 2009-05-01). All procedures were con-
ducted in accordance with the ‘Guide for Care and Use of 
Laboratory Animals’ published by the National Institutes 
of Health and the ethical guidelines of the International 
Association for the Study of Pain. 
Experimental animals
  Male ICR mice (MJ Co., Seoul, Korea) weighing 20∼25 
g were used for all the experiments. Animals were housed 
5 per cage in a room maintained at 22±0.5
oC with an alter-
nating 12 hr light-dark cycle. Food and water were avail-
able ad libitum. The animals were allowed to adapt to the 
laboratory for at least 2 hr before testing and were only 
used once. Experiments were performed during the light 
phase of the cycle (10:00∼17:00). 120 SH Park, et al
Oral administration, and intraperitoneal (i.p.) and 
intrathecal (i.t.) injections
  Oral administration was performed with gage in a vol-
ume of 500 μl/25 g body weight. I.p. injection was conducted 
to unanesthesized mice with volume of 250 μl. The i.t. ad-
ministration was performed following the method of Hylden 
and Wilcox [13,14] using a 30-gauge needle connected to 
a 25 μl Hamilton syringe with polyethylene tubing. The 
i.t. injection volume was 5 μl and the injection site was 
verified by injecting a similar volume of 1% methylene blue 
solution and determining the distribution of the injected 
dye in the spinal cord. The dye injected i.t. was distributed 
both rostrally and caudally but with short distance (about 
0.5 cm from the injection site) and no dye was found visu-
ally in the brain. The success rate for the injections was 
consistently found to be over 95%, before the experiments 
were done.
Assessment of antinociception and experimental proto-
cols
  All assessments for measuring antinociceptive properties 
of Agrimonia pilosa Ledeb extract were carried out by blind-
ed observers.
Tail-flick and hot-plate tests
  Antinociception was determined by the tail-flick [15] and 
the hot-plate paw-licking tests [16]. For the measurement 
of the tail-flick latency, mice were gently held with one 
hand with the tail positioned in the apparatus (EMDIE 
Instrument Co., Maidens, VA, USA, Model TF6) and the 
tail-flick response was elicited by applying radiant heat to 
the dorsal surface of the tail. The intensity of radiant heat 
was adjusted so that the animal flicked its tail within 3 
to 5 sec. For the hot-plate test, mice were individually 
placed on the 55
oC hot-plate apparatus (Itic Life Science, 
Woodland Hills, CA, USA, Model 39 Hot Plate) and then, 
the reaction time starting from the placement of the mouse 
on the hotplate to the time of licking the front paw was 
measured. Basal latency for the hot-plate test was approx-
imately 9 sec. Animals were pretreated orally once with ve-
hicle (control) or Agrimonia pilosa Ledeb extract at 200 
mg/kg doses 30 min prior to performing the tail-flick or 
hot-plate tests.
Acetic acid-induced writhing test
  For the writhing test [17], 1% acetic acid was injection 
i.p. and then, the animals were immediately placed in an 
acrylic observation chamber (20 cm high, 20 cm diameter). 
The number of writhes was counted during 30 min after 
the injection of acetic acid. A writhe was defined as a con-
traction of the abdominal muscles accompanied by an ex-
tension of the forelimbs and elongation of the body. Animals 
were pretreated orally once with vehicle (control) or 
Agrimonia pilosa Ledeb extract at 200 mg/kg doses 30 min 
prior to performing the acetic acid-induced writhing and 
formalin tests.
Substance P-induced nociceptive behavioral test
  Vehicle (control) or 200 mg/kg of Agrimonia pilosa Ledeb 
extract was pretreated orally 30 min prior to performing 
i.t. injection of substance P (0.7 μg/5 μl). Immediately after 
i.t. injection with substance P the mice were placed in an 
observation chamber (20 cm high, 20 cm diameter) and 
their nociceptive behavioral responses were recorded dur-
ing 30 min. The cumulative response time of licking, 
scratching and biting episodes directed toward the lumbar 
and caudal region of spinal cord were measured with a 
stop-watch timer [14].
Pretreatment of antagonists
  At first, mice were pretreated i.p. with either saline, na-
loxone (5 mg/kg), methysergide (5 mg/kg), or yohimbine (5 
mg/kg), 10 min before oral administration of vehicle as a 
control or a fixed dose of Agrimonia pilosa Ledeb extract 
(200 mg/kg). And then, the writhing response was tested 
30 min after the treatment with either vehicle or Agrimonia 
pilosa Ledeb extract [18-22].
Drugs
  Acetic acid, substance P, naloxone, methysergide and yo-
himbine were purchased from Sigma Chemical Co. (St. 
Louis, MO, USA). Agrimonia pilosa Ledeb (300 g) was dis-
solved in 80% ethanol (1,500 ml) and extracted as refluxing 
for 3 hours, and then the extract was filtered for obtaining 
A. This process was repeated again once to obtain B from 
residue. A and B were mixed. This mixture was decom-
pressed and dried for using as Agrimonia pilosa Ledeb 
extract. Agrimonia pilosa Ledeb extract, naloxone, methy-
sergide and yohimbine were dissolved in saline. All drugs 
were prepared just before use.
Statistical analysis
  Data were presented as the mean±SEM. The statistical 
significance of differences between groups was assessed 
with one-way ANOVA with Bonferroni’s post-hoc test using 
GraphPad Prism version 4.0 for Windows Vista (GraphPad 
Software, San Diego, CA, USA); p＜0.05 was considered 
significant.
RESULTS
Effect of Agrimonia pilosa Ledeb extract on the tail- 
flick and hot-plate paw-licking responses
  As revealed in Fig. 1, oral treatment of Agrimonia pilosa 
Ledeb extract at the dose of 200 mg/kg increased latencies 
of the tail-flick and hot-plate paw-licking responses com-
pare to the control group of mice. The sedative effect was 
manifested, when the mice were treated with Agrimonia pi-
losa Ledeb extract orally at the dose of 200 mg/kg. However, 
there were no paralysis and motor changes.
Effect of Agrimonia pilosa Ledeb extract on the nocicep-
tive behavior induced by acetic acid and substance P
  Agrimonia pilosa Ledeb extract attenuated the acetic 
acid-induced writhing numbers (Fig. 2A). Treatment with 
Agrimonia pilosa Ledeb extract at the dose of 200 mg/kg 
led to 68% decrease in the acetic acid-induced writhing re-
sponse compare to the control group of mice. In vehicle- Antinociception of Agrimonia pilosa Ledeb 121
Fig. 1. The antinociceptive effect of Agrimonia pilosa Ledeb extract administered orally in the tail-flick and hot-plate tests. Mice were 
administered orally with either vehicle or 200 mg/kg of Agrimonia pilosa Ledeb extract and the tail-flick (A) or hot-plate (B) response 
was measured at 30 min after treatment. Acetaminophen is positive control. The vertical bars denote the standard error of the mean. 
The number of animal used for each group was 8∼10 (*p＜0.05, **p＜0.01 compared to the vehicle-treated control group of mice).
Fig. 2. Effect of Agrimonia pilosa Ledeb extract on the nociceptive response induced by various pain models. Agrimonia pilosa Ledeb extract 
(200 mg/kg) was administered orally and then, 0.25 ml of 1% acetic acid solution was injected intraperitoneally 30 min after treatment. 
The number of writhing was counted for 30 min following acetic acid injection (A). Agrimonia pilosa Ledeb extract (200 mg/kg) was 
administered orally for 30 min prior to the substance P (0.7 μg per 5 μl) injection intrathecally (B). The cumulative response time of 
licking, scratching and biting episodes was measured for 30 min. Acetaminophen is positive control. The vertical bars indicate the standard
error of the mean. The number of animal used for each group was 8∼10 (***p＜0.001, compared with control group).
treated control mice, i.t. injection of substance P (0.7 μg) 
caused acute, immediate behavioral responses, i.e., licking, 
scratching and biting the lumbar or caudal region, which 
lasted about 30 min. As shown in Fig. 2B, cumulative noci-
ceptive response times for i.t. administration of substance 
P was significantly diminished by 85%.
Effect of opioidergic, serotonergic and adrenergic 
system on the inhibition of writhing response induced 
by Agrimonia pilosa Ledeb extract
  We examined the possible involvement of opioidergic, se-
rotonergic and adrenergic system in the Agrimonia pilosa 
Ledeb extract-induced antinociception. The pretreatment 
with naloxone (opioid receptor antagonist, Fig. 3A) or me-
thysergide (serotonergic receptor antagonist, Fig. 3B) did 
not affect Agrimonia pilosa Ledeb extract-induced antino-
ciception. However, the blockade of α 2-adrenergic receptor 
with systemic pre-administration of yohimbine abolished 
the  Agrimonia pilosa Ledeb extract-induced inhibition of 
the writhing response (Fig. 3C). The treatment of naloxone, 
methysergide or yohimbine itself did not affect the writhing 
response (Fig. 3).
DISCUSSION
  In the present study, we found that Agrimonia pilosa 
Ledeb extract administered orally produces antinociception 
in various pain models. The tail-flick response is believed 
to be a spinally mediated reflex and the paw-licking hot-
plate response is a more complex supraspinally organized 
behavior (for review, see [23]). Moreover, Grumbach [24] 
has shown that the effectiveness of analgesic agents in the 
tail-flick pain model is highly correlated with relief of hu-
man pain. Our results demonstrate that Agrimonia pilosa 122 SH Park, et al
Fig. 3. Effect of naloxone (A), methysergide (B) and yohimbine (C) injected intraperitoneally (i.p.) on inhibition of the writhing response 
induced by Agrimonia pilosa Ledeb extract administered orally. Naloxone, methysergide, or yohimbine (5 mg/kg) was pretreated 
intraperitoneally for 10 min, before oral administration of vehicle or Agrimonia pilosa Ledeb extract (200 mg/kg). Agrimonia pilosa Ledeb
extract or vehicle was administered orally and then, 0.25 ml of 1% acetic acid solution was injected i.p. 30 min after treatment. The number
of writhing was counted for 30 min following acetic acid injection. The vertical bars denote the standard error of the mean. The number 
of animal used for each group was 8∼10 (***p＜0.001, compared with control group).
Ledeb extract causes to prolong the tailflick and hot-plate 
response latencies, indicating the increase of nociceptive 
threshold. 
  We also examined the effect of Agrimonia pilosa Ledeb 
extract on the acetic acid-induced writhing test. I.p. injec-
tion of acetic acid can produce the peritoneal inflammation 
(acute peritonitis), which cause a response characterized by 
contraction of the abdominal muscles accompanying an ex-
tension of the forelimbs and elongation of the body. This 
writhing response is considered as a visceral inflammatory 
pain model [17 for review, see 25]. In the present study, 
we clearly showed the antinociceptive effect of Agrimonia 
pilosa Ledeb extract in an acetic acid-induced writhing test. 
Furthermore, it has been reported that i.t. injection of sub-
stance P in mice can also elicit nociceptive responses, con-
sisting of biting, scratching and licking the caudal parts 
of the body [14,26]. We found in the present study that 
Agrimonia pilosa Ledeb extract was also effective in attenu-
ating substance P-induced nociceptive responses. These re-
sults suggest furthermore that Agrimonia pilosa Ledeb ex-
tract may exert their antinociceptive effect via the central 
sites, possibly spinally mediated mechanisms.
  The roles of opioid, serotonergic and adrenergic receptors 
in the regulation of modulation of nociceptive processing 
have been demonstrated in many previous studies. For ex-
ample, it is well known that opioid receptors are involved 
in the antinociception [27-29]. Also, it has been reported 
that blockade of the spinal serotonergic or noradrenergic 
receptors by spinal injection of methysergide or yohimbine 
antagonize the antinociception induced by morphine ad-
ministered supraspinally [28,30,31]. We observed in the 
present study that α 2-adrenergic receptor, but not opioider-
gic and serotonergic receptors, appear to be involved in or-
ally administered Agrimonia pilosa Ledeb extract-induced 
antinociception.
  In conclusion, our results suggest that Agrimonia pilosa 
Ledeb extract shows an antinociceptive property in various 
pain models. Furthermore, this antinociceptive effect of 
Agrimonia pilosa Ledeb extract may be mediated by α 2- 
adrenergic receptor, but not opioidergic and serotonergic 
receptors. 
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